Browse by UCL people
Group by: Type | Date
Number of items: 5.
Article
Panchal, N;
Booth, C;
Cannons, JL;
Schwartzberg, PL;
(2018)
X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective.
Frontiers in Immunology
, 9
, Article 666. 10.3389/fimmu.2018.00666.
|
 |
|
Panchal, N;
Houghton, B;
Diez, B;
Ghosh, S;
Ricciardelli, I;
Thrasher, AJ;
Gaspar, HB;
(2018)
Transfer of gene corrected T cells corrects humoral and cytotoxic defects in X-linked lymphoproliferative disease (XLP1).
Journal of Allergy and Clinical Immunology
, 142
(1)
235-245.e6.
10.1016/j.jaci.2018.02.053.
|
|
|
Piras, G;
Montiel-Equihua, C;
Chan, Y-KA;
Wantuch, S;
Stuckey, D;
Burke, D;
Prunty, H;
... Gaspar, HB; + view all
(2020)
Lentiviral Hematopoietic Stem Cell Gene Therapy Rescues Clinical Phenotypes in a Murine Model of Pompe Disease.
Molecular Therapy - Methods and Clinical Development
, 18
pp. 558-570.
10.1016/j.omtm.2020.07.001.
|
|
Conference item
|
Panchal, N;
Hougton, B;
Diez, B;
Thrasher, AJ;
Gaspar, HB;
Booth, C;
(2017)
T Cell Gene Therapy Corrects Humoral and Cytotoxic Defects in X-Linked Lymphoproliferative Disease (XLP).
Presented at: 20th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), Washington, DC, United States.
|
Thesis
|
Panchal, Neelam;
(2020)
Developing novel therapies for X-linked lymphoproliferative disease type 1.
Doctoral thesis (Ph.D), UCL (University College London).
|
